Identification of a novel nonsense mutation and a missense substitution in the AGPAT2 gene causing congenital generalized lipodystrophy type 1

Ítems similars

• Identification of a SLC19A2 nonsense mutation in Persian families with thiamine-responsive megaloblastic anemia
  per: Setoodeh, Aria, et al.
  Publicat: (2013)
• Metreleptin and Metformin Use in an Infant With Congenital Generalized Lipodystrophy Secondary to AGPAT2 Mutation
  per: Schweisberger, Cintya, et al.
  Publicat: (2021)
• Diazoxide-unresponsive congenital hyperinsulinism associated with ABCC8 nonsense mutation
  per: Hussain, Suhaimi, et al.
  Publicat: (2015)
• Molecular Mechanisms of Hepatic Steatosis and Insulin Resistance in the AGPAT2 Deficient Mouse Model of Congenital Generalized Lipodystrophy
  per: Cortés, Víctor A., et al.
  Publicat: (2009)
• Leu124Serfs*26, a novel AGPAT2 mutation in congenital generalized lipodystrophy with early cardiovascular complications
  per: Montenegro Junior, Renan Magalhães, et al.
  Publicat: (2020)